• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRCA1 和 BRCA2 基因检测结果在三级保健中心进行基因检测后的医疗保健提供者之间的沟通。

Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center.

机构信息

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.

出版信息

Fam Cancer. 2011 Dec;10(4):673-9. doi: 10.1007/s10689-011-9460-z.

DOI:10.1007/s10689-011-9460-z
PMID:21681553
Abstract

Individuals at high risk for hereditary cancers often receive genetic counseling and testing at tertiary care centers; however, they may receive care for long-term management of their cancer risk in community settings. Communication of genetic test results to health care providers outside of tertiary care settings can facilitate the long-term management of high risk individuals. This study assessed women's communication of BRCA1/BRCA2 genetic test results to health care providers outside of tertiary care settings (termed "outside" health care providers, or OHCPs) and women's perceptions regarding communication of results. Women (n = 312) who underwent BRCA1/BRCA2 genetic counseling and testing completed a questionnaire assessing whether or not they shared test results with OHCPs and perceptions regarding the communication of test results to OHCPs. Most (72%) shared genetic test results with OHCPs. Women with no personal history of cancer were more likely to have shared results compared to women with a personal history of cancer. Mutation status did not significantly predict sharing of genetic information. Most reported positive perceptions regarding the disclosure of genetic test results to OHCPs. The majority did not report any concerns about potential insurance discrimination (88%) and indicated that OHCPs were able to appropriately address their questions (81%). Although most women shared their genetic test results with OHCPs, those with a personal history of cancer may need further encouragement to share this information. Tertiary care centers should facilitate outreach and education with OHCPs in order to assure appropriate long-term cancer risk management for high risk populations.

摘要

具有遗传性癌症高风险的个体通常在三级护理中心接受遗传咨询和检测;然而,他们可能在社区环境中接受癌症风险的长期管理。将遗传测试结果传达给三级护理环境之外的医疗保健提供者可以促进高风险个体的长期管理。本研究评估了女性向三级护理环境之外的医疗保健提供者(称为“外部”医疗保健提供者,或 OHCP)传达 BRCA1/BRCA2 遗传测试结果的情况,以及女性对结果传达的看法。接受 BRCA1/BRCA2 遗传咨询和检测的女性(n=312)完成了一份问卷,评估她们是否与 OHCP 共享测试结果,以及对向 OHCP 传达测试结果的看法。大多数(72%)与 OHCP 共享了遗传测试结果。与有癌症个人病史的女性相比,没有癌症个人病史的女性更有可能共享结果。突变状态并未显著预测遗传信息的共享。大多数女性对向 OHCP 透露遗传测试结果的看法表示积极。大多数女性没有报告任何对潜在保险歧视的担忧(88%),并表示 OHCP 能够恰当地回答她们的问题(81%)。尽管大多数女性与 OHCP 共享了她们的遗传测试结果,但那些有癌症个人病史的女性可能需要进一步鼓励来共享这些信息。三级护理中心应促进与 OHCP 的外联和教育,以确保高危人群的适当长期癌症风险管理。

相似文献

1
Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center.BRCA1 和 BRCA2 基因检测结果在三级保健中心进行基因检测后的医疗保健提供者之间的沟通。
Fam Cancer. 2011 Dec;10(4):673-9. doi: 10.1007/s10689-011-9460-z.
2
Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.女性接受BRCA1和BRCA2检测的经历:德国遗传性乳腺癌和卵巢癌联盟调查的组织情况及明斯特的初步数据。
Community Genet. 2003;6(4):249-58. doi: 10.1159/000079387.
3
Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.将BRCA1和BRCA2检测结果告知高危亲属:一项癌症风险评估项目的经验
Am J Med Genet C Semin Med Genet. 2003 May 15;119C(1):11-8. doi: 10.1002/ajmg.c.10003.
4
Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.基于计算机的决策辅助工具对乳腺癌易感性基因检测的知识、认知及意愿的影响:一项随机对照试验。
JAMA. 2004 Jul 28;292(4):442-52. doi: 10.1001/jama.292.4.442.
5
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。
JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987.
6
Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.癌症风险信息共享:接受BRCA1/2突变基因咨询的个体的经历。
J Health Commun. 2017 Feb;22(2):143-152. doi: 10.1080/10810730.2016.1258743. Epub 2017 Jan 23.
7
Providers' perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American women.医疗服务提供者对非裔美国女性进行BRCA1/2基因咨询与检测的看法及做法。
J Genet Couns. 2011 Dec;20(6):674-89. doi: 10.1007/s10897-011-9396-3. Epub 2011 Aug 6.
8
"I Don't Want to Be an Ostrich": Managing Mothers' Uncertainty during BRCA1/2 Genetic Counseling.“我不想做鸵鸟”:在BRCA1/2基因咨询过程中应对母亲们的不确定性
J Genet Couns. 2017 Jun;26(3):455-468. doi: 10.1007/s10897-016-9998-x. Epub 2016 Jul 30.
9
Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.选择进行BRCA1/2或遗传性非息肉病性结直肠癌(HNPCC)基因易感性检测的个体在应对方式、疾病认知、疾病经历、家庭系统特征和遗传性癌症困扰方面的比较。
Patient Educ Couns. 2007 Jan;65(1):58-68. doi: 10.1016/j.pec.2006.05.006. Epub 2006 Jul 26.
10
Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.女性家庭成员对先证者所分享的BRCA1/2基因检测结果不确定为阴性缺乏理解。
J Genet Couns. 2019 Oct;28(5):950-961. doi: 10.1002/jgc4.1147. Epub 2019 Jun 14.

引用本文的文献

1
Clinical Cancer and Direct-to-Consumer Genetic Test Result-Sharing Behavior: Findings from HINTS 2020.临床癌症与直接面向消费者的基因检测结果分享行为:来自2020年健康信息全国趋势调查(HINTS)的发现
J Pers Med. 2022 Dec 22;13(1):18. doi: 10.3390/jpm13010018.
2
Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: findings from the Health Information National Trends Survey.接受和分享高穿透性癌症基因检测结果的患病率及其相关因素:来自健康信息国家趋势调查的结果
Public Health Genomics. 2015;18(2):67-77. doi: 10.1159/000368745.
3
Public awareness of genetic nondiscrimination laws in four states and perceived importance of life insurance protections.

本文引用的文献

1
Hereditary breast and ovarian cancer: referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting.遗传性乳腺癌和卵巢癌:在社区环境中,向遗传评估转诊来源,并与非遗传临床医生就评估进行沟通。
Genet Med. 2010 Jan;12(1):25-31. doi: 10.1097/GIM.0b013e3181c60955.
2
Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.BRCA1/2 突变携带者癌症风险降低策略的生存分析。
J Clin Oncol. 2010 Jan 10;28(2):222-31. doi: 10.1200/JCO.2009.22.7991. Epub 2009 Dec 7.
3
Comparisons of patient and physician expectations for cancer survivorship care.
四个州公众对基因非歧视法的认知以及人寿保险保护的感知重要性。
J Genet Couns. 2015 Jun;24(3):512-21. doi: 10.1007/s10897-014-9771-y. Epub 2014 Sep 23.
4
Establishing a program for individuals at high risk for breast cancer.为乳腺癌高危个体建立项目。
J Cancer. 2013 Jul 1;4(5):433-46. doi: 10.7150/jca.6481. Print 2013.
5
Do Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers?在肿瘤护理环境中接受检测的乳腺癌患者会与家庭成员和医疗服务提供者分享BRCA基因突变结果吗?
J Cancer Epidemiol. 2012;2012:498062. doi: 10.1155/2012/498062. Epub 2012 Jul 15.
患者与医生对癌症生存护理期望的比较。
J Clin Oncol. 2009 May 20;27(15):2489-95. doi: 10.1200/JCO.2008.20.3232. Epub 2009 Mar 30.
4
ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.美国妇产科医师学会实践公报第103号:遗传性乳腺癌和卵巢癌综合征
Obstet Gynecol. 2009 Apr;113(4):957-966. doi: 10.1097/AOG.0b013e3181a106d4.
5
Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.对接受BRCA有害突变检测的患者进行筛查及降低风险手术的认知。
Cancer. 2009 Apr 15;115(8):1598-604. doi: 10.1002/cncr.24199.
6
Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study.生殖与激素因素,以及BRCA1和BRCA2突变携带者患卵巢癌的风险:国际BRCA1/2携带者队列研究结果
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):601-10. doi: 10.1158/1055-9965.EPI-08-0546. Epub 2009 Feb 3.
7
Genetics education for health professionals: a context.面向卫生专业人员的遗传学教育:一种背景情况。
J Genet Couns. 2008 Apr;17(2):145-51. doi: 10.1007/s10897-007-9126-z. Epub 2007 Oct 19.
8
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.妇科肿瘤学家协会教育委员会关于遗传性妇科癌症易感性风险评估的声明。
Gynecol Oncol. 2007 Nov;107(2):159-62. doi: 10.1016/j.ygyno.2007.09.031.
9
Meta-analysis of BRCA1 and BRCA2 penetrance.BRCA1和BRCA2基因外显率的荟萃分析。
J Clin Oncol. 2007 Apr 10;25(11):1329-33. doi: 10.1200/JCO.2006.09.1066.
10
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.美国癌症协会关于以MRI作为乳房X线摄影辅助手段进行乳房筛查的指南。
CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89. doi: 10.3322/canjclin.57.2.75.